📊 Score Breakdown
Offering Ability
60
Cash Runway
0
Float Risk
27
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
29%
📉 Score Deterioration
40%
• Score rose 17 points recently (worsening)
🔄 Reverse Split
30%
• 50-day avg $1.54 approaching $1 threshold
💹 Market Data
Market Cap$18.41M
Shares Outstanding9.85M
Float7.03M
Cash$21.94M
Debt$2.35M
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↑ 369.1% shares (2025Q4 vs prior)
22 institutional holders · 3.25M shares
#1
Alyeska Investment Group, L.P.
957.5K shares
#2
FRANKLIN RESOURCES INC
914.5K shares
#3
683 Capital Management, LLC
724.6K shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest161.8K
Days to Cover3.1
% of Float2.3%
FINRA data as of May 15, 2026
📁 Recent SEC Activity
xbrl
XBRL CONVERTIBLE
Dec 31, 2022
xbrl
XBRL WARRANT
Dec 31, 2020
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for INAB
📊 INAB FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 INAB Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.